Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib
| dc.contributor.author | Zhang, Lei | |
| dc.contributor.author | Ramchandren, Radhakrishnan | |
| dc.contributor.author | Robertson, Michael J. | |
| dc.contributor.author | Avivi, Irit | |
| dc.contributor.author | Rowe, Jacob M. | |
| dc.contributor.author | Herbrecht, Raoul | |
| dc.contributor.author | Van Hoof, Achiel | |
| dc.contributor.author | Egyed, Miklos | |
| dc.contributor.author | Besisik, Sevgi | |
| dc.contributor.author | Witzig, Thomas E. | |
| dc.contributor.author | Heise, Carla | |
| dc.contributor.author | Fu, Tommy | |
| dc.contributor.author | Cicero, Sherri | |
| dc.contributor.author | Goy, Andre | |
| dc.contributor.author | Williams, Michael E. | |
| dc.contributor.author | Drach, Johannes | |
| dc.date.accessioned | 2021-03-05T19:58:49Z | |
| dc.date.available | 2021-03-05T19:58:49Z | |
| dc.identifier.citation | Goy A., Williams M. E. , Besisik S., Drach J., Ramchandren R., Robertson M. J. , Avivi I., Rowe J. M. , Herbrecht R., Van Hoof A., et al., "Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib", 55th Annual Meeting of the American-Society-of-Hematology, Louisiana, Amerika Birleşik Devletleri, 7 - 10 Aralık 2013, cilt.122 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_d1d4941b-12b2-4bd5-846e-271cf19c093d | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/138668 | |
| dc.identifier.uri | https://doi.org/10.1182/blood.v122.21.3057.3057 | |
| dc.language.iso | eng | |
| dc.subject | Hematoloji | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | HEMATOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.title | Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib | |
| dc.type | Bildiri | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 122 | |
| dc.contributor.firstauthorID | 836951 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]